A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).

Clinical trial NCT05895136 · RECRUITING

Trial details

NCT number: NCT05895136
Sponsor: European Foundation for Study of Chronic Liver Failure
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Liver Cirrhosis Decompensated Cirrhosis of Liver Acute on Chronic Liver Failure (ACLF)

Start date: 2024-07-01
Primary completion: 2025-09-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.